DBD.VN Binh Dinh Pharmaceutical and Medical Equipment JSC

Healthcare Drug Manufacturers - Specialty & Generic Vietnam Stocks
Add to portfolio Ask AI about DBD.VN
45,750 VND
Close of Oct 30, 2026
45,600 52,133
Market cap
VND 4.34T
P/E
15.0x
P/B
2.50x
ROE
19.5%
Dividend yield
4.28%
Fundamental score
2.5/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is DBD.VN undervalued?

Graham number
Price45,750
Graham value35,448
Premium29.1%

DBD.VN trades 29.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Binh Dinh Pharmaceutical and Medical Equipment JSC fundamental analysis

12 of 22 checks passed

ROE 1/2

Moderate return on equity (19.5%), between 10% and 20%.

ROA 1/1

Return on assets (12.1%) is above the industry median (11.7%).

Profit Consistency 2/2

Profitable for 6 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (5.0%) is not above the 5-year average (12.9% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (5.0%) is below the industry median (5.0%).

Revenue Growth 1/2

Revenue grew 6.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (13.0%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 136.4x against interest expense, well covered.

PE vs Market 0/1

PE (15.1x) is above the market median (11.2x).

PE vs Industry 0/1

PE (15.1x) is above the industry median (13.1x).

PBV 0/1

Price to book (2.5x) is above the industry median (2.2x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 37.8, limit 22.5).

PEG 0/1

PEG on 5-year earnings growth is 1.17, above 1.

Dividend Yield 1/2

Dividend yield (4.3%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 63.6%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Binh Dinh Pharmaceutical and Medical Equipment JSC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Binh Dinh Pharmaceutical and Medical Equipment JSC

Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs; vitamins and minerals; endocrine hormones; respiratory drugs; anti…

Full company profile